The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3.
Tomotake KanaiNaoki KondoMasayasu OkadaHiroshige SanoGo OkumuraYasufumi KijimaAkira OgoseHiroyuki KawashimaNaoto EndoPublished in: Journal of orthopaedic surgery and research (2020)
We demonstrated the existence of an MMP-3 suppression mechanism that utilizes the JNK pathway in RA-FLS. We consider that the JNK pathway could be a target for future RA therapies.